185 related articles for article (PubMed ID: 18395147)
21. Salvage therapy for Hodgkin's lymphoma.
Quddus F; Armitage JO
Cancer J; 2009; 15(2):161-3. PubMed ID: 19390313
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin lymphoma: Late effects of treatment and guidelines for surveillance.
Ng AK; van Leeuwen FE
Semin Hematol; 2016 Jul; 53(3):209-15. PubMed ID: 27496313
[TBL] [Abstract][Full Text] [Related]
23. Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.
Matasar MJ; Ford JS; Riedel ER; Salz T; Oeffinger KC; Straus DJ
J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25717170
[TBL] [Abstract][Full Text] [Related]
24. Clinical practice guidelines for the psychosocial care of cancer survivors: current status and future prospects.
Jacobsen PB
Cancer; 2009 Sep; 115(18 Suppl):4419-29. PubMed ID: 19731353
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
26. Long-term effects of high-dose chemotherapy and radiation for relapsed and refractory Hodgkin's lymphoma.
Goodman KA; Riedel E; Serrano V; Gulati S; Moskowitz CH; Yahalom J
J Clin Oncol; 2008 Nov; 26(32):5240-7. PubMed ID: 18809615
[TBL] [Abstract][Full Text] [Related]
27. Survey of long-term follow-up programs in the United States for survivors of childhood brain tumors.
Bowers DC; Adhikari S; El-Khashab YM; Gargan L; Oeffinger KC
Pediatr Blood Cancer; 2009 Dec; 53(7):1295-301. PubMed ID: 19688835
[TBL] [Abstract][Full Text] [Related]
28. Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.
Yu AF; Jones LW
Future Cardiol; 2015 Jul; 11(4):441-52. PubMed ID: 26234325
[TBL] [Abstract][Full Text] [Related]
29. [Position paper of the Society of Pediatric Oncology and Hematology (GPOH) on (long-term) surveillance, (long-term) follow-up and late effect evaluation in pediatric oncology patients].
Calaminus G; Kaatsch P
Klin Padiatr; 2007; 219(3):173-8. PubMed ID: 17525912
[No Abstract] [Full Text] [Related]
30. ACR Appropriateness Criteria on Hodgkin's lymphoma: favorable prognosis stage I and II.
Das P; Ng A; Constine LS; Hodgson DC; Mendenhall NP; Morris DE; Yunes MJ; Chauvenet AR; Hudson MM; Winter JN
J Am Coll Radiol; 2008 Oct; 5(10):1054-66. PubMed ID: 18812149
[TBL] [Abstract][Full Text] [Related]
31. Subsequent malignant neoplasms in cancer survivors.
Ng AK; Travis LB
Cancer J; 2008; 14(6):429-34. PubMed ID: 19060610
[TBL] [Abstract][Full Text] [Related]
32. Impact of treatment-related cardiac toxicity on lymphoma survivors: an institutional approach for risk reduction and management.
Walsh MC
Clin J Oncol Nurs; 2010 Aug; 14(4):505-7. PubMed ID: 20682507
[TBL] [Abstract][Full Text] [Related]
33. Medical issues in cancer survivors--a review.
Miller KD; Triano LR
Cancer J; 2008; 14(6):375-87. PubMed ID: 19060602
[TBL] [Abstract][Full Text] [Related]
34. Follow-up care after childhood cancer: survivors' expectations and preferences for care.
Michel G; Greenfield DM; Absolom K; Ross RJ; Davies H; Eiser C;
Eur J Cancer; 2009 Jun; 45(9):1616-23. PubMed ID: 19328676
[TBL] [Abstract][Full Text] [Related]
35. Long-term risk of cardiovascular disease in Hodgkin lymphoma survivors--retrospective cohort analyses and a concept for prospective intervention.
Andersson A; Näslund U; Tavelin B; Enblad G; Gustavsson A; Malmer B
Int J Cancer; 2009 Apr; 124(8):1914-7. PubMed ID: 19165857
[TBL] [Abstract][Full Text] [Related]
36. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials.
Bar Ad V; Paltiel O; Glatstein E
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1472-9. PubMed ID: 19028275
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcomes in Hodgkin lymphoma survivors. Temporary trends and comparison with general population.
Núñez-García B; Clemente MB; Sánchez JC; Royuela A; Ibargüen BCS; Méndez M; López-Ibor JV; Martínez M; Traseira C; Garitaonaindia Y; Aguado R; Calvo V; Torrente M; Parejo C; Provencio Z; Provencio M
Hematol Oncol; 2023 Aug; 41(3):407-414. PubMed ID: 36934306
[TBL] [Abstract][Full Text] [Related]
38. Late effects of treatment for Hodgkin lymphoma.
Friedman DL; Constine LS
J Natl Compr Canc Netw; 2006 Mar; 4(3):249-57. PubMed ID: 16507272
[TBL] [Abstract][Full Text] [Related]
39. A questionnaire based review of long-term follow-up programs for survivors of childhood cancer in Canada.
Guilcher GM; Fitzgerald C; Pritchard S
Pediatr Blood Cancer; 2009 Jan; 52(1):113-5. PubMed ID: 18821577
[TBL] [Abstract][Full Text] [Related]
40. Late effects of pediatric cancer treatment come into sharper focus, predictive tests are emerging.
McNeil C
J Natl Cancer Inst; 2006 Jul; 98(13):882-4. PubMed ID: 16818847
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
